ZEB1 and central nervous system cancer: A low TET2 level in MA cells could be due to low gene dosage, but could also involve other mechanisms such as repression by ZEB1 as reported in glioma [22]; MA cells express a high level of ZEB1 as a part of their EMT program [12].